Fundies.
English

Outlook Therapeutics, Inc.

EDGAR
OTLK Quarterly report (10-Q) · filed 2026-08-18

Annual consolidated revenue for 2025: about Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 1.414M, using the latest reported figures.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

1.51 million Unit_Standard_USD_5ij6QP3qmES-fjghYr0C_Q

2025 Q3 · Unit_Standard_USD_5ij6QP3qmES-fjghYr0C_Q

Exact inputs and evidence
  • Revenue: 1505322 Unit_Standard_USD_5ij6QP3qmES-fjghYr0C_Q Source
Cash and cash equivalents
11.2 million Unit_Standard_USD_MuqQ9rkhHkqAiaNC2_uNTA Source
Exact value

11242068 Unit_Standard_USD_MuqQ9rkhHkqAiaNC2_uNTA

Long-term debt including current maturities
967 million Unit12 Source
Exact value

967055000 Unit12

Shares outstanding
187 million Unit_Standard_shares_TttxTE2iMESXlZCBcwajGw Source
Exact value

187096998 Unit_Standard_shares_TttxTE2iMESXlZCBcwajGw

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-18.

Financial data available through: 2025-09-30.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2025-09-30
  • Operating income: 2 of 11 periods available· newest 2025-09-30
  • Net income: 2 of 11 periods available· newest 2025-09-30
  • Operating cash flow: 2 of 11 periods available· newest 2025-09-30
  • Capital expenditure: 2 of 11 periods available· newest 2019-09-30
  • Total assets: Multiple units; comparison withheld· newest 2025-09-30
  • Total liabilities: Multiple units; comparison withheld· newest 2025-09-30
  • Current assets: Multiple units; comparison withheld· newest 2025-09-30
  • Current liabilities: Multiple units; comparison withheld· newest 2025-09-30
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-09-30
  • Long-term debt including current maturities: 2 of 11 periods available· newest 2019-09-30
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 12.94 million

    Prior period

    −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 75.37 million

    –

    Current period

    −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 62.42 million

    –

    Exact inputs and evidence

    -62424863 − -75366714 = 12941851 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ

    -75366714 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -62424863 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 16.96 million

    Prior period

    −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 68.79 million

    –

    Current period

    −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 51.83 million

    –

    Exact inputs and evidence

    -51829437 − -68793858 = 16964421 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ

    -68793858 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -51829437 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2024-10-01 – 2025-09-30

  • Revenue Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 1.41 million 100% of revenue
  • Cost of revenue Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 1.36 million 96% of revenue
  • Operating expenses Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 67.12 million 4,748% of revenue
  • Operating income −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 67.06 million −4,744% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 4.64 million −328% of revenue
  • Net income −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 62.42 million −4,416% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 51.83 million −3,667% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2025 Operating loss: operating costs were 4,844% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2025 2024-10-01 – 2025-09-301413535 68475201 Derived -67061666 -4636803 Derived -62424863 Unavailable
Source

Amounts are exact, in Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 1.4M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.5M1.1M763.3K381.7K0.02025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ)Source evidence
2025Revenue1413535

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2025Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -4,744.3% 2025
Net margin -4,416.2% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.380%-996%-2,372%-3,748%-5,124%2025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2025Operating margin-4,744.3%
2025Net margin-4,416.2%
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ -51.8M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.1M-10.9M-25.9M-40.9M-56.0M2025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ)Source evidence
2025Operating cash flow-51829437

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ)Source evidence
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2025-09-30Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2025-09-30Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2023-10-01 – 2024-09-30
−Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 75.37 million
Exact value

Exact value: -75366714 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ

2023-10-01 – 2024-09-30: -75366714 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 68.79 million
Exact value

Exact value: -68793858 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ

2023-10-01 – 2024-09-30: -68793858 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2024-10-01 – 2025-09-30
−Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 62.42 million
Exact value

Exact value: -62424863 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ

2024-10-01 – 2025-09-30: -62424863 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ 51.83 million
Exact value

Exact value: -51829437 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ

2024-10-01 – 2025-09-30: -51829437 Unit_Standard_USD_BKgXWjmzJEmwFLDEBZshDQ Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

69 filings · 3,916 latest values · 3,916 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001649989, 1649989, OTLK, edgar:1649989, ons, otlk

Also known as OUTLOOK THERAPEUTICS, INC., OUTLOOK THERAPEUTICS, INC., Oncobiologics, Inc., Outlook Therapeutics, Inc.